Mefatinib

• UNSPSC Description:

  Mefatinib is a potent tyrosine kinase inhibitor with antineoplastic activity[1].

• Target Antigen:

  c-Met/HGFR

• Type:

  Reference compound

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/mefatinib.html

• Solubility:

  H2O : 100 mg/mL (ultrasonic)

• Smiles:

  OC(/C=C\C(O)=O)=O.O=C(NC1=CC2=C(NC3=CC=C(C(Cl)=C3)F)N=CN=C2C=C1OC(F)F)/C=C/CN(C)C.OC(/C=C\C(O)=O)=O

• Molecular Weight:

  698.00

• References & Citations:

  [1]WHO Drug Information-World Health Organization (WHO).

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1989592-50-8